Serum neopterin and indoleamine 2,3-dioxyg activity are promising biomarkers for presence and progression of hepatitis B

Serum neopterin and indoleamine 2,3-dioxyg activity are promising biomarkers for presence and progression of hepatitis B

Bibliographic Details
Main Authors:	Wang Liming, Zhu Yabi, Liu Yangyang, Zhou Fangming, Lv Chunxiao
Format:	Article
Language:	English
Published:	De Gruyter 2022-06-01
Series:	Pteridines
Online Access:	https://doi.org/10.1515/pteridines-2022-0037

Similar Items

Serum Neopterin Levels and IDO Activity as Possible Markers for Presence and Progression of Hepatitis B
by: Koç Deniz Öğütmen, et al.
Published: (2020-06-01)

Neopterin suppresses the activity of tryptophan-degrading enzyme indoleamine 2,3-dioxygenase in human peripheral blood mononuclear cells
by: Schroecksnadel Sebastian, et al.
Published: (2013-12-01)

Neopterin, a promising biomarker for the diagnosis of intraocular inflammation
by: N. B. Kuryltsiv, et al.
Published: (2021-06-01)

Plasma and Urine Indoleamine 2,3-Dioxygenase Activity: Promising Biomarkers for Chronic Kidney Disease and Inflammation Status
by: Hong H, et al.
Published: (2022-09-01)

Neopterin: A Promising Candidate Biomarker for Severe COVID-19
by: Hailemichael W, et al.
Published: (2021-02-01)

Manipulation of indoleamine 2,3-dioxygenase (IDO) for clinical transplantation: promises and challenges.
by: Quan, J, et al.
Published: (2008)

Manipulation of indoleamine 2,3-dioxygenase (IDO) for clinical transplantation: promises and challenges
by: Quan, J, et al.
Published: (2008)

Upregulation of indoleamine 2,3-dioxygenase in hepatitis C virus infection.
by: Larrea, E, et al.
Published: (2007)

Indoleamine 2,3-dioxygenase in endometriosis
by: Hui-Li Yang, et al.
Published: (2019-01-01)

Serum indoleamine 2,3-dioxygenase level and diagnostic value in patients with rosacea
by: Merve Sena Odabasi, et al.
Published: (2023-01-01)

Assessment of Serum Neopterin as a Biomarker in Peripheral Artery Disease
by: Agnieszka Zembron-Lacny, et al.
Published: (2021-10-01)

Contribution of indoleamine 2,3-dioxygenase in preeclampsia
by: Mona F.M El-Karn, et al.
Published: (2016-01-01)

Serum Neopterin and its Significance as Biomarker in Differentiation of Mods From Sepsis
by: Zhang Xiaohong, et al.
Published: (2018-12-01)

Effects of indoleamine 2,3-dioxygenase deficiency on high-fat diet-induced hepatic inflammation.
by: Junji Nagano, et al.
Published: (2013-01-01)

Rational design of indoleamine 2,3-dioxygenase inhibitors.
by: Röhrig, U, et al.
Published: (2010)

Expression of Indoleamine 2,3-Dioxygenase Induced by IFN-γ and TNF-α as Potential Biomarker of Prostate Cancer Progression
by: Irina Banzola, et al.
Published: (2018-05-01)

Forty‐three key gene expressions involved in the effect of indoleamine 2,3‐dioxygenase 1 expression on cancer prognosis may be a potential indoleamine 2,3‐dioxygenase 1 inhibitor biomarker
by: Weirui Li, et al.
Published: (2021-02-01)

Serum Neopterin in Patients with Malignant Melanoma
by: Beneš Petr, et al.
Published: (2009-02-01)

Serum Neopterin - Possible Marker to Predict Progression of Dilated Cardiomyopathy
by: Samsonov Mikhail, et al.
Published: (1990-09-01)

Indoleamine 2,3-dioxygenase level and oxidative stress parameters in the serum of patients with chronic renal failure
by: F. M. Y. Saeed, et al.
Published: (2023-08-01)

Indoleamine 2,3-Dioxygenase (IDO) Activity: A Perspective Biomarker for Laboratory Determination in Tumor Immunotherapy
by: Pengbo Yang, et al.
Published: (2023-07-01)

IL-32 induces indoleamine 2,3-dioxygenase+CD1c+ dendritic cells and indoleamine 2,3-dioxygenase+CD163+ macrophages: Relevance to mycosis fungoides progression
by: Hanako Ohmatsu, et al.
Published: (2017-02-01)

Changes of serum neopterin and its significance as biomarker in prediction the prognosis of patients with acute pancreatitis
by: Zhang Lefeng, et al.
Published: (2020-09-01)

Role of indoleamine 2,3-dioxygenase in pathology of the gastrointestinal tract
by: Aleksandar Acovic, et al.
Published: (2018-12-01)

Indoleamine 2,3-Dioxygenase and Tolerance: Where Are We Now?
by: Andrew L. Mellor, et al.
Published: (2017-10-01)

Clinical Value of Serum Neopterin in Breast Cancer
by: Suzy Gohar, et al.
Published: (2018-12-01)

Serum neopterin is elevated in patients infected with <it>Shigella</it>
by: Singh Kirnpal-Kaur, et al.
Published: (2010-08-01)

Serum Neopterin Concentration in Children with Viral Gastroenteritis
by: Plata-Nazar Katarzyna, et al.
Published: (2010-02-01)

Salivary and serum neopterin and interleukin 6 as biomarkers in patients with oral and oropharyngeal squamous cell carcinoma
by: Saskova Lenka, et al.
Published: (2022-12-01)

Serum HBV RNA: a promising biomarker for blood product safety screening and enhanced diagnostic efficiency in chronic hepatitis B virus infection
by: Sulan Yu, et al.
Published: (2023-08-01)

Adenosine Triphosphate in Serum as a Promising Biomarker for Differential Diagnosis of Hepatitis B Disease Progression
by: Caorui Lin, et al.
Published: (2022-07-01)

Deficiency of immunoregulatory indoleamine 2,3-dioxygenase 1in juvenile diabetes.
by: Orabona, C, et al.
Published: (2018)

Indoleamine 2,3-dioxygenase: distribution and function in the developing human placenta.
by: Kudo, Y, et al.
Published: (2004)

Decreased tryptophan catabolism by placental indoleamine 2,3-dioxygenase in preeclampsia.
by: Kudo, Y, et al.
Published: (2003)

Local Inhibition of Indoleamine 2,3-Dioxygenase Mitigates Renal Fibrosis
by: Camilla Grønkjær Jensen, et al.
Published: (2021-07-01)

Comprehensive behavioral analysis of indoleamine 2,3‐dioxygenase knockout mice
by: Nao Hirata, et al.
Published: (2018-09-01)

Indoleamine 2,3- Dioxygenase: A Novel Immunotherapeutic Target for Osteosarcoma
by: Asim Farooq, et al.
Published: (2022-09-01)

The paradoxical patterns of expression of indoleamine 2,3-dioxygenase in colon cancer
by: Ding Ya, et al.
Published: (2009-08-01)

The Role of Indoleamine 2,3-Dioxygenase in Diethylnitrosamine-Induced Liver Carcinogenesis.
by: Yuhei Shibata, et al.
Published: (2016-01-01)

The Role of Indoleamine-2,3-Dioxygenase in Cancer Development, Diagnostics, and Therapy
by: Lilla Hornyák, et al.
Published: (2018-01-01)